Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
NCT ID | NCT03719690 |
Title | Safety and Efficacy of Tipifarnib in Head and Neck Cancer With HRAS Mutations and Impact of HRAS on Response to Therapy (AIM-HN/SEQ-HN) |
Recruitment | Recruiting |
Gender | both |
Phase | Phase II |
Variant Requirements | Yes |
Sponsors | Kura Oncology, Inc. |
Indications |
head and neck squamous cell carcinoma |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA | ITA | ESP | DEU | BEL | AUT |